3IQG image
Entry Detail
PDB ID:
3IQG
Keywords:
Title:
Structure of O-Acetylserine Sulfhydrylase in Complex with Peptide MNWNI
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2009-08-20
Release Date:
2009-11-17
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.20
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
I 41
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Cysteine synthase
Chain IDs:A (auth: X)
Chain Length:316
Number of Molecules:1
Biological Source:Haemophilus influenzae
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
LLP A LYS ?
Primary Citation
Design of o-acetylserine sulfhydrylase inhibitors by mimicking nature.
J.Med.Chem. 53 345 356 (2010)
PMID: 19928859 DOI: 10.1021/jm901325e

Abstact

The inhibition of cysteine biosynthesis in prokaryotes and protozoa has been proposed to be relevant for the development of antibiotics. Haemophilus influenzae O-acetylserine sulfhydrylase (OASS), catalyzing l-cysteine formation, is inhibited by the insertion of the C-terminal pentapeptide (MNLNI) of serine acetyltransferase into the active site. Four-hundred MNXXI pentapeptides were generated in silico, docked into OASS active site using GOLD, and scored with HINT. The terminal P5 Ile accounts for about 50% of the binding energy. Glu or Asp at position P4 and, to a lesser extent, at position P3 also significantly contribute to the binding interaction. The predicted affinity of 14 selected pentapeptides correlated well with the experimentally determined dissociation constants. The X-ray structure of three high affinity pentapeptide-OASS complexes were compared with the docked poses. These results, combined with a GRID analysis of the active site, allowed us to define a pharmacophoric scaffold for the design of peptidomimetic inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures